期刊文献+

一例成人Xp11.2易位性肾癌的临床特征及影像学表现

下载PDF
导出
摘要 Xp11.2易位性肾癌是2004年世界卫生组织(WHO)肾细胞癌病理组织学分类中新增的类型,因其基因特征亦称Xp11.2易位/转录因子E3 (translocationfacor E3,TFE3)基因融合相关性肾细胞癌,虽然其总体发病率很低,但在儿童肾癌患者中约1/3为此类肾癌[1,2],本院遇见1例最终由重庆医科大学附一院术后病理确诊的成人少见Xp11.2易位性肾细胞癌的完整临床影像学随诊过程,长达4年多的随访资料有一定特点,报告如下,以期提高对本病的认识和合理处置.
出处 《实用医技杂志》 2020年第8期1092-1094,共3页 Journal of Practical Medical Techniques
  • 相关文献

参考文献10

二级参考文献58

  • 1庞涛,刘群,马祥兴,王新怡,董杰,李爱银.肾脏集合管癌的CT诊断[J].中华放射学杂志,2004,38(10):1094-1098. 被引量:22
  • 2饶秋,周晓军,吴波,马恒辉,周航波,刘晓红,陈洁宇.Xp11.2易位/TFE3基因融合相关性肾癌的病理特征与临床分析[J].中华病理学杂志,2007,36(4):244-246. 被引量:36
  • 3Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunore activity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol, 2003, 27:750-761.
  • 4Zagoria R J, Wolfman NT, Karstaedt N, et al. CT features of renal cell carcinoma with emphasis on relation to tumor size. Invest Radiol, 1990,25:261-266.
  • 5Argani P, Olgac S, Tickoo SK, et al. Xpl 1 translocation renal cell careinoma in adults: expand clinical pothologic, and genetic spectrum. Am J Surg Pathol, 2007, 31 : 1149 -1160.
  • 6Jayasinghe C, Siegler N, Leuschner I, et al. Renal Cell carcinoma with Xpl 1.2 translocation in a 7-year-old boy. Klin Padiatr,2010, 222 : 187-189.
  • 7Ross H, Argani P. Xpll translocation renal cell carcinoma- Pathology,2010, 42:369-373.
  • 8Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer,2008,112 : 1607-1616.
  • 9Aoyagi T, Shinohara N, Kubota-Chikai K, et al. Long-term survival in a patient with node-positive adult-onset Xpl 1.2 translocation renal cell carcinoma. Urol Int,2011,86:487-490.
  • 10Schinstine M, Filie AC, Torres-Cabala C, et al. Fine-needle aspiration of a Xpll. 2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung:report of a case and review of the literature. Diagn Cytopathol,2006 ,34 :751-756.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部